Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"immunoassays"

Slides: 1–8 of 8
Add to tray Remove from tray

Overview: Results for Diagnostic Testing

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: overview | diagnostic testing | immunoassays | sensitivity | specificity
Add to tray Remove from tray

Overview: Conclusions

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: conclusions | diagnostic assays | patient outcomes | prevention | treatment | overview
Add to tray Remove from tray

Comparative Effectiveness of Diagnostic Assays for C.difficile

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | cell cytotoxicity assay | immunoassays | toxigenic culture | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Assays Commonly Used in CDI Diagnostics

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | C. difficile culture | cytotoxicity assay | immunoassays | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Methods Evaluated for Detecting Toxigenic C.difficile

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | glutamate dehydrogenase | immunoassays | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Results of Direct Comparisons of Available Diagnostic Assays

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | immunoassays | results | sensitivity | specificity | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Background: Antinuclear Antibody Test

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: antinuclear antibody test | ANA testing | autoimmune conditions | systemic lupus erythematosus | Sjögrens syndrome | systemic sclerosis | indirect immunofluorescence | enzyme immunoassay | ELISA
Add to tray Remove from tray

Background: Rheumatoid Factor Test

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: rheumatoid factor test | autoantibodies | Fc fragment | immunoglobulin G | IgG | 19S IgM-RF isotope | rheumatoid arthritis | juvenile idiopathic arthritis
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364